These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 30338692)

  • 21. The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.
    Schrem H; Reichert B; Frühauf N; Becker T; Lehner F; Kleine M; Bektas H; Zachau L; Klempnauer J
    Ann Transplant; 2012; 17(3):5-13. PubMed ID: 23018250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
    Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
    Kawakita S; Everly MJ
    Clin Transpl; 2013; ():13-22. PubMed ID: 25095488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAR, SOFT AND DRI POST-HEPATIC TRANSPLANTATION: WHAT IS THE BEST FOR SURVIVAL ANALYSIS?
    Torterolli F; Watanabe RK; Tabushi FI; Peixoto IL; Nassif PAN; Tefilli NL; Rocha SL; Malafaia O
    Arq Bras Cir Dig; 2021; 34(1):e1576. PubMed ID: 34133523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival-benefit estimation.
    Åberg F; Nordin A; Mäkisalo H; Isoniemi H
    Scand J Gastroenterol; 2015; 50(9):1144-51. PubMed ID: 25865580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of adult liver re-transplant patients in the model for end-stage liver disease era: is it time to reconsider its indications?
    Montenovo MI; Hansen RN; Dick AA
    Clin Transplant; 2014 Oct; 28(10):1099-104. PubMed ID: 25041109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.
    Hong JC; Yersiz H; Kositamongkol P; Xia VW; Kaldas FM; Petrowsky H; Farmer DG; Lipshutz G; Markovic D; Hiatt JR; Busuttil RW
    Arch Surg; 2011 Sep; 146(9):1017-23. PubMed ID: 21930997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing donor characteristics in liver transplantation over the last 10 years in Canada.
    Sela N; Croome KP; Chandok N; Marotta P; Wall W; Hernandez-Alejandro R
    Liver Transpl; 2013 Nov; 19(11):1236-44. PubMed ID: 23913790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
    Paviglianiti A; Ruggeri A; Volt F; Sanz G; Milpied N; Furst S; Esquirol A; Arcese W; Picardi A; Ferra C; Ifrah N; Bourhis JH; Raj K; von dem Borne PA; Sica S; Menard AL; Bloor A; Kenzey C; Gluckman E; Rocha V
    Br J Haematol; 2017 Dec; 179(5):790-801. PubMed ID: 29048109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
    Maluf DG; Edwards EB; Kauffman HM
    Transplantation; 2006 Dec; 82(12):1653-7. PubMed ID: 17198254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time.
    Blok JJ; Putter H; Metselaar HJ; Porte RJ; Gonella F; de Jonge J; van den Berg AP; van der Zande J; de Boer JD; van Hoek B; Braat AE
    Transplant Direct; 2018 Sep; 4(9):e382. PubMed ID: 30234151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.
    Li Z; Hu Z; Xiang J; Zhou J; Yan S; Wu J; Zhou L; Zheng S
    Liver Transpl; 2014 Jan; 20(1):35-45. PubMed ID: 24142889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.